| # | Drug | Count |
|---|---|---|
| 0 | LEUPROLIDE ACETATE | 44 |
| 1 | NALTREXONE | 38 |
| 2 | ARIPIPRAZOLE LAUROXIL | 29 |
| 3 | DUPILUMAB | 27 |
| 4 | CABOTEGRAVIR | 16 |
| 5 | ARIPIPRAZOLE | 15 |
| 6 | BOTULINUM TOXIN TYPE A | 15 |
| 7 | DENOSUMAB | 14 |
| 8 | ALBUTEROL SULFATE | 13 |
| 9 | LANREOTIDE ACETATE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CANTHARIDIN | 4 | 0.0219 |
| 1 | ARIPIPRAZOLE LAUROXIL | 29 | 0.0063 |
| 2 | LUMASIRAN | 1 | 0.0026 |
| 3 | LENACAPAVIR SODIUM | 1 | 0.0020 |
| 4 | CABOTEGRAVIR | 16 | 0.0020 |
| 5 | HYALURONIC ACID | 2 | 0.0017 |
| 6 | LANREOTIDE ACETATE | 13 | 0.0016 |
| 7 | GIVOSIRAN SODIUM | 2 | 0.0013 |
| 8 | NALTREXONE | 38 | 0.0012 |
| 9 | BOTULINUM TOXIN TYPE A | 15 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Acetylcholine Release Inhibitor [EPC] | 27 |
| 1 | Interleukin-4 Receptor alpha Antagonist [EPC] | 27 |
| 2 | Neuromuscular Blocker [EPC] | 27 |
| 3 | Corticosteroid [EPC] | 19 |
| 4 | Atypical Antipsychotic [EPC] | 15 |
| 5 | RANK Ligand Inhibitor [EPC] | 14 |
| 6 | Anti-IgE [EPC] | 13 |
| 7 | Benzodiazepine [EPC] | 12 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 10 |
| 9 | Azole Antifungal [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 2 | Pyrethroid [EPC] | 1 | 0.0006 |
| 3 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 4 | Acetylcholine Release Inhibitor [EPC] | 27 | 0.0003 |
| 5 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 6 | 0.0002 |
| 6 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 7 | Catechol-O-Methyltransferase Inhibitor [EPC] | 1 | 0.0002 |
| 8 | TRPM8 Thermoreceptor Agonist [EPC] | 1 | 0.0002 |
| 9 | Anti-IgE [EPC] | 13 | 0.0001 |